Gitelman Syndrome: a Сlinical and Molecular Overview
Journal Title: Нирки - Year 2015, Vol 3, Issue 13
Abstract
Gitelman syndrome (OMIM #263800) is an autosomal recessive renal tubular disorder due to loss of function mutations of SLC12A3 gene, encoding the thiazide-inhibitable, electroneutral Na+-Cl– cotransporter (NCC) of the distal convoluted tubule. Clinical consequences include chronic normotensive hypokalemic alkalosis, hypomagnesemia, hypocalciuria, polyuria/nocturia, chronic asthenia, muscular cramps, chondrocalcinosis and rarely cardiac arrhythmias. Impaired reabsorption of glomerular filtrate through NCC drives compensatory reabsorption of Na+ in more distal tubular segments (connecting and cortical collecting tubules) via both the «electrogenic» channel ENa (which also enhances tubular secretion of potassium and protons, explaining the hypokalemic alkalosis), and pendrin-dependent electroneutral NaCl reabsorption. Thus volume depletion is seldom severe in these patients. There exists wide variability and severity of clinical symptoms between subjects, ranging from an almost asymptomatic disease to a severely disabling one. More than 400 SLC12A3 mutations have been so far described, evenly distributed along the protein sequence and without any hot spot. Mutation detection rate by gene sequencing actually is about 80 %. There are no genotype-phenotype correlations. Commonly considered a benign condition, Gitelman syndrome may be associated with reduced quality of life, increased medicalization and high hospitalization rate.
Authors and Affiliations
Maria Luisa QUERQUES, Federica Ravera, Alberto MENEGOTTO, Giacomo COLUSSI
Keywords
Related Articles
- EP ID EP215051
- DOI -
- Views 103
- Downloads 0
2017 World Kidney Day in Ukraine
.
Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min/1.73 m2) European renal best practice
.
Research-to-practice “Clinical case in nephrology. 11th REENA™ CME Course”: a review of key issues
.
Hormone-dependent Nephrotic Syndrome, Relapsing Secondary to Allergy, in 9-year-old Child and its Treatment with Omalizumab
.
Effective treatment and prevention of recurrent urinary tract infections by using Cysto-aurin®, a Solidago virgaurea preparation
We conducted a study of clinical and laboratory efficacy, as well as evaluated the effect on the quality of life of intermittent therapy with Cysto-aurin drug in 96 patients with recurrent urinary tract infection (UTI)....